Intellectual Property India Publishes Patent Application for Heterocyclic Compound For Inducing Degradation Of Kras Protein

MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202647085591 A) filed by Astellas Pharma Inc. on July 13, 2026, for Heterocyclic Compound For Inducing Degradation Of Kras Protein.

Inventors include Morikawa, Takahiro; Imada, Sunao; Ukegawa, Naoya; Sato, Ryo; Kawaminami, Eiji; Okumura, Mitsuaki Number; Fujiwara, Yuta; Yoshinari, Tomohiro; and Nishizono, Yoshihiro.

The application for the patent was published on July 17, 2026, under issue no. 29/2026.

Abstract: Provided is a compound useful as an active ingredient in a pharmaceutical composition for treating cancer. The present inventors have examined a compound useful as an active ingredient in a pharmaceutical composition for cancer treatment, an...